Pharmacy Practice Exam Review Flashcards

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/99

flashcard set

Earn XP

Description and Tags

Practice flashcards covering nonsterile compounding, ethical principles, internal medicine, biostatistics, and oncology based on NAPLEX review material.

Last updated 4:24 PM on 7/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

100 Terms

1
New cards

Comminution

The process of reducing particle size using techniques such as grinding, crushing, jointing, or vibrating.

2
New cards

Trituration

The act of grinding a powder to reduce particle size or the process of mixing two or more powders together.

3
New cards

Geometric dilution

A compounding technique used when mixing two ingredients of unequal quantities to ensure the even distribution of the smaller quantity throughout the mixture.

4
New cards

NAPQI

The toxic metabolite of acetaminophen characteristically produced through the CYP4502E1CYP450\,2E1 metabolic pathway.

5
New cards

Autonomy

The ethical principle of respecting an individual's right to make informed decisions about their healthcare that align with their values and preferences.

6
New cards

Beneficence

The medical ethical principle of intending to do good and maximize benefit for the patient.

7
New cards

Justice

The ethical principle of treating people fairly and without discrimination, often focused on in public health and drug distribution policies.

8
New cards

Nonmaleficence

The ethical principle that a provider should choose actions that do not cause harm, such as avoiding unnecessary procedures.

9
New cards

Informed consent

The process of fully educating a patient on the nature, alternatives, risks, and benefits of a medical intervention to ensure an educated decision.

10
New cards

Confidentiality

The principle of protecting patient information from unauthorized disclosure, foundational to laws like the Health Insurance Portability and Accountability Act (HIPAA).

11
New cards

Koplik spots

Small, white spots located on the inside of a patient's cheeks that are a clinical characteristic of the childhood disease Measles.

12
New cards

SABAs

Inhaled short-acting beta-2 agonists (e.g., albuterol) used for as-needed symptom relief (reliever therapy) in asthma.

13
New cards

Levalbuterol (Xopenex HFA)

The R-isomer of albuterol that may be considered for patients unable to tolerate albuterol due to adverse effects like palpitations.

14
New cards

Palpitations

An adverse effect of SABAs resulting from the stimulation of beta-2 receptors in vascular smooth muscle causing peripheral vasodilation and reflex tachycardia.

15
New cards

Tremors

An adverse effect of SABAs resulting from the stimulation of beta-2 receptors in skeletal muscle, which increases neuromuscular excitability.

16
New cards

Hypokalemia

An electrolyte abnormality caused by SABAs which increase Na+/K+ATPaseNa^{+}/K^{+}-ATPase activity, shifting potassium into cells.

17
New cards

Vaccine Information Statement (VIS)

A document developed by the CDC for each vaccine that describes the benefits and risks of vaccination and must be given to patients prior to every dose.

18
New cards

Flolan

A prostacyclin analogue medication primarily indicated for the treatment of pulmonary arterial hypertension.

19
New cards

Atrial fibrillation

An arrhythmia that impairs the atria's ability to move blood effectively, potentially causing blood to pool and form a left atrial thrombus.

20
New cards

Left atrial thrombus

A blood clot that can form in the heart due to atrial fibrillation and potentially travel to the brain, causing a cardioembolic stroke.

21
New cards

CHA2DS2-VASc

A scoring tool used to estimate the annual percent risk of stroke in patients with nonvalvular atrial fibrillation based on specific risk factors.

22
New cards

DOAC

Direct-acting oral anticoagulants such as apixaban, edoxaban, rivaroxaban, and dabigatran, which are often preferred over warfarin for stroke prevention in AF.

23
New cards

ISMP

The Institute for Safe Medication Practices, which maintains a list of look-alike and sound-alike (LASA) drug names to minimize medication errors.

24
New cards

Tall man lettering

The use of bolded, uppercase letters to draw attention to differences in similar drug names (e.g., DOBUTamine and DOPamine) to reduce confusion.

25
New cards

Alkylating agents

A class of chemotherapy drugs, such as cyclophosphamide, that inhibits DNA and protein synthesis and is cell cycle nonspecific.

26
New cards

Anthracyclines

A class of chemotherapy drugs (e.g., doxorubicin) that binds DNA to inhibit synthesis and repair via topoisomerase II inhibition; notable for causing cardiotoxicity.

27
New cards

Folate antimetabolites

A chemotherapy class (e.g., methotrexate) that interferes with enzymes in folic acid synthesis, preventing purine and pyrimidine production in the S phase.

28
New cards

Vinca alkaloids

A chemotherapy class, such as vincristine, that inhibits microtubule formation in the M phase of the cell cycle.

29
New cards

Measles, mumps, and rubella (MMR) vaccine

A live vaccine that must be administered at least 3-11months3\text{-}11\,months after products containing immune globulins.

30
New cards

Oxytrol patch

A transdermal formulation of oxybutynin used for urinary incontinence that is changed twice weekly.

31
New cards

Parkinson disease psychosis

A condition characterized by paranoid delusions and visual hallucinations, often triggered by medications that increase dopamine activity.

32
New cards

Levodopa

The component of Sinemet that acts as a prodrug of dopamine to treat the motor symptoms of Parkinson disease.

33
New cards

Absolute Risk Reduction (ARR)

The difference in risk between a control group and a treatment group, calculated as Control Group Event RateTreatment Group Event Rate\text{Control Group Event Rate} - \text{Treatment Group Event Rate}.

34
New cards

Alpha level (α\alpha)

A prespecified accepted risk of committing a type I error (false positive conclusion) in a clinical study.

35
New cards

p-value

The probability of observing a result due to chance; it must be less than the alpha level (α\alpha) for a result to be statistically significant.

36
New cards

Alteplase

An intravenous fibrinolytic used for reperfusion therapy in acute ischemic stroke, ideally administered within 4.5hours4.5\,hours of symptom onset.

37
New cards

Nimodipine

A lipophilic dihydropyridine calcium channel blocker only indicated to improve neurological outcomes following subarachnoid hemorrhage.

38
New cards

Graves' disease

An autoimmune condition leading to the overproduction of thyroid hormones (T3T3, T4T4).

39
New cards

Propylthiouracil (PTU)

The preferred treatment for hyperthyroidism during the first trimester of pregnancy due to causing less severe fetal abnormalities than alternatives.

40
New cards

Methimazole

The preferred thionamide for Graves' disease, except during the first trimester of pregnancy or when treating thyroid storm.

41
New cards

Motion sickness treatment options

Pharmacotherapeutic options for adults include Transderm-Scop, dimenhydrinate, and meclizine.

42
New cards

Hartford dosing nomogram

A tool used to determine the administration frequency of aminoglycosides (gentamicin and tobramycin) when using extended-interval dosing.

43
New cards

Extended-interval dosing

An aminoglycoside dosing strategy using higher doses (e.g., 7mg/kg7\,mg/kg) administered less frequently (every 2424, 3636, or 48hours48\,hours) based on random levels.

44
New cards

Allopurinol

A xanthine oxidase inhibitor for gout that is associated with severe hypersensitivity reactions (e.g., Stevens-Johnson Syndrome) and requires screening for HLA-B5801HLA\text{-}B^{*}5801.

45
New cards

HLA-B*5801

A genetic allele that, if present, increases a patient's risk of severe cutaneous adverse reactions to the medication allopurinol.

46
New cards

KRAS mutation wild-type

The genetic status a tumor must have for EGFR inhibitors (e.g., cetuximab) to be effective in metastatic colorectal cancer.

47
New cards

Cetuximab

A monoclonal antibody that inhibits the epidermal growth factor receptor (EGFR); it is only effective in KRAS mutation wild-type tumors.

48
New cards

HLA-B*1502

A genetic marker that increases the risk of serious skin reactions to carbamazepine, oxcarbazepine, and fosphenytoin.

49
New cards

INSTIs

Integrase strand transfer inhibitors (e.g., bictegravir, dolutegravir) which are recommended as part of the initial antiretroviral regimen for most HIV-treatment patients.

50
New cards

Atropine

The treatment administered for the reversal of symptoms in organophosphate poisoning, such as excess salivation and lacrimation.

51
New cards

Triptan sensations

Adverse effects of triptans (e.g., sumatriptan) characterized by transient pressure or heaviness on the chest or neck region.

52
New cards

Sumatriptan (Imitrex) repeat dosing

For oral tablets, a second dose may be administered no sooner than 2hours2\,hours after the initial dose if symptoms return.

53
New cards

ISO 7

The required air quality standard for the buffer room where sterile compounded products are prepared.

54
New cards

Aztreonam

A monobactam antibiotic with only gram-negative activity (including Pseudomonas aeruginosa) that is safe for use in patients with a penicillin allergy.

55
New cards

Drospirenone

A progestin in certain oral contraceptives with antimineralocorticoid activity that can decrease potassium excretion and increase the risk of hyperkalemia.

56
New cards

Levothyroxine

A synthetic T4T4 replacement and the treatment of choice for primary hypothyroidism.

57
New cards

Enoxaparin (Lovenox)

The preferred anticoagulant for the treatment of venous thromboembolism in pregnant patients.

58
New cards

Osmolarity

A measure of concentration describing the total number of particles in 1liter1\,liter of solution, measured in mOsmol/LmOsmol/L.

59
New cards

Heparin-Induced Thrombocytopenia (HIT)

An antibody-mediated prothrombotic state suspected when the platelet count drops by >50%>\,50\% from baseline following heparin exposure.

60
New cards

Simvastatin/Cyclosporine interaction

A contraindicated drug combination because cyclosporine (a strong CYP3A4 inhibitor) increases simvastatin concentrations, elevating the risk of rhabdomyolysis.

61
New cards

Secondary hyperparathyroidism

A CKD complication triggered by hyperphosphatemia and vitamin D deficiency, resulting in bone and mineral disorders.

62
New cards

Doxercalciferol

An active vitamin D analog used to treat secondary hyperparathyroidism in patients with advanced chronic kidney disease.

63
New cards

Acrolein

A toxic metabolite produced by cyclophosphamide and ifosfamide that causes urothelial toxicity and hemorrhagic cystitis.

64
New cards

Mesna

An adjunctive treatment that inactivates acrolein in the bladder to prevent hemorrhagic cystitis caused by ifosfamide and high-dose cyclophosphamide.

65
New cards

Cardura XL

An alpha-blocker OROS formulation (doxazosin) that may leave an empty insoluble shell, or 'ghost tablet,' in the patient's stool.

66
New cards

Left Shift

A laboratory finding of an elevated band count (immature neutrophils), typically indicating an acute bacterial infection or inflammation.

67
New cards

Sodium zirconium cyclosilicate

A potassium-binding resin used to increase gastrointestinal potassium elimination in the treatment of hyperkalemia.

68
New cards

Humalog

A rapid-acting insulin brand whose 'in use' vials are stable when stored at room temperature for 28days28\,days.

69
New cards

Inpatient CAP Antibiotic Selection (Nonsevere)

Preferred regimens include a beta-lactam (e.g., ceftriaxone) combined with either a macrolide or doxycycline.

70
New cards

Doxorubicin lifetime cumulative dose

The maximum lifetime exposure limited to 450-550mg/m2450\text{-}550\,mg/m^2 to prevent dose-limiting cardiotoxicity.

71
New cards

Primary outcome

The main endpoint in a clinical trial (e.g., mean change in A1C) that the study is specifically designed to evaluate.

72
New cards

FOLFIRI

A chemotherapy regimen for colorectal cancer consisting of fluorouracil, leucovorin, and irinotecan.

73
New cards

Biktarvy

A single-tablet HIV regimen containing bictegravir, emtricitabine, and tenofovir alafenamide.

74
New cards

Complera

A single-tablet HIV regimen containing emtricitabine, tenofovir disoproxil fumarate, and rilpivirine.

75
New cards

Valganciclovir

An antiviral medication used for CMV colitis that requires dose adjustments based on the patient's creatinine clearance (CrClCrCl).

76
New cards

Cockcroft-Gault Equation

The mathematical formula used to estimate creatinine clearance (CrClCrCl) for the purposes of drug dosing.

77
New cards

HIPAA

The Health Insurance Portability and Accountability Act, a federal law protecting patient privacy.

78
New cards

Respiratory alkalosis

An acid-base disorder defined by a pH >7.45>\,7.45 and a low pCO2pCO_2 (<35mmHg<\,35\,mmHg), commonly resulting from hyperventilation.

79
New cards

Metabolic acidosis

An acid-base disorder defined by a low pH and low serum bicarbonate (HCO3HCO_3^{-}).

80
New cards

Anion gap

A laboratory calculation (Na+(Cl+HCO3)Na^{+} - (Cl^{-} + HCO_3^{-})) used to identify and evaluate metabolic acidosis.

81
New cards

D5/NSD5/NS Osmolarity

The total osmolarity of an IV fluid containing 5% dextrose and 0.9% sodium chloride, approximately 560mOsmol/L560\,mOsmol/L.

82
New cards

Norepinephrine

A vasopressor that acts primarily as an alpha-1 agonist to increase blood pressure in patients with septic shock.

83
New cards

Phentolamine

An alpha-blocker administered to treat tissue damage caused by the extravasation of vasopressors.

84
New cards

Bacteroides fragilis

An anaerobic gram-negative pathogen covered by the antibiotic Zosyn (piperacillin/tazobactam).

85
New cards

Emtricitabine

A nucleoside reverse transcriptase inhibitor (NRTI) component in HIV products such as Truvada and Descovy.

86
New cards

Tenofovir disoproxil fumarate (TDF)

An NRTI prodrug of tenofovir associated with renal impairment and bone mineral density loss.

87
New cards

Tenofovir alafenamide (TAF)

A newer NRTI prodrug of tenofovir associated with a lower risk of renal and bone toxicities compared to TDF.

88
New cards

Rilpivirine

An NNRTI used in HIV regimens that requires an acidic environment for absorption; its use is contraindicated with PPIs.

89
New cards

Nitrate-free interval

A required period of at least 10-12hours10\text{-}12\,hours daily to prevent the development of tolerance to long-acting nitrate formulations.

90
New cards

T-score

A measurement from a DXA scan where a score >1>\,-1 is considered normal bone mineral density.

91
New cards

Anticipatory nausea and vomiting

A conditioned response occurring before a chemotherapy cycle that can be managed with a benzodiazepine (e.g., lorazepam).

92
New cards

G6PD deficiency

A genetic condition that is a contraindication for rasburicase and pegloticase due to the risk of hemolytic anemia.

93
New cards

Colesevelam

A bile acid sequestrant that binds intestinal bile acids to decrease cholesterol levels.

94
New cards

Fibrates

A class of medications (e.g., fenofibrate) that activates PPAR-alpha to decrease triglyceride levels.

95
New cards

Ora-Plus

An oral suspending vehicle used in the preparation of nonsterile compounded suspensions.

96
New cards

Non-PVC materials

Specialized bags and tubing required for taxanes (e.g., paclitaxel) to prevent leaching of the plasticizer diethylhexyl phthalate (DEHP).

97
New cards

0.22 micron filter

The specific filter size required during the infusion of taxanes like paclitaxel to protect patients from particulate matter.

98
New cards

Spiriva HandiHaler

A dry powder inhaler device where the patient inserts a tiotropium capsule and pierces it before inhalation.

99
New cards

Toujeo SoloStar

A long-acting insulin glargine formulation with a concentration of 300units/mL300\,units/mL.

100
New cards

Triptan Contraindications

Use is avoided in patients with cerebrovascular disease, ischemic heart disease, or uncontrolled hypertension due to vascular effects.